◆ 会议时间：2020年3月4-6日 会议取消
◆ 会议地点：日本 横滨
◆ 下届会议：2021年第93届日本胃癌协会年会(JGCA2021)


◆ 会议简介：

日本胃癌协会(JGCA) 第92届年会将于2020年3月4日-3月6日在日本横滨举行。日本胃癌协会（JGCA）的前身成立于1962年的日本胃癌研究学会，其使命是通过举办学术会议、出版刊物，提高人们对胃癌的认识，促进胃癌的研究、教育和培训，与相关组织联系协作等，促进和发展胃癌的基础与临床研究并促进其诊断和治疗，为社会做出贡献（未经本站许可，禁止复制摘录转载本站任何内容-领域国际医学会议网）。

大会主题 ： Beyond the frontier ～次世代の科学に基づいた胃癌診療を考える～

演讲主题征集时间： 2019年8月1日～9月17日

Message from Congress President

It is my pleasure to announce that the 92nd Annual Meeting of the Japanese Gastric Cancer Association will be held from March 4th to 6th, 2020, at PACIFICO Yokohama (Yokohama Minato Mirai).

While there has been a decline in the morbidity and mortality rate of gastric cancer, there still currently remains approximately 50,000 patient deaths caused by gastric cancer in Japan, and the development of new methods of diagnosis and treatment for gastric cancer is desired more than ever before.

The progress in medicine has advanced with the progress of science and technology beginning from the end of the last century, such as new computer technology, materials technology, molecular biology technology, and information technology, which have now become integrated into actual life, and also, with respect to medical treatment, there have been significant changes in diagnosis and medical treatment such as the introduction of genomic medicine last year, the development of new diagnostic techniques, robotic surgery, molecular-targeted therapy, and personalized medicine. The environment of the health science is changing drastically in clinical aspects including aging patients and public healthcare issues. Although the number of gastric cancer patients will increase in a next decade, it is projected to decrease substantially in 20–30 years in Japan. Therefore, the consolidation and specialization of gastric cancer medicine are required. While the reduction in patients suffering from gastric cancer is an extraordinary achievement for medical professionals, it is considered necessary for medical professionals treating gastric cancer to propose and create new clinical models to transition from conventional methods of treatment.

The theme for the Meeting is “Beyond the frontier - Consideration of next-gen practice of gastric cancer based on the new science,” and our aim is to consider and discuss topics together on how the future of gastric cancer treatment will change in Japan, and how we should change it, by solving current issues with leading-edge science. In particular, while learning about new treatment methods and research to contribute to the future of gastric cancer treatment, we also wish to seek the future direction of the Japanese Gastric Cancer Association at this 92nd Annual Meeting.

As before, we will be holding various symposiums including those inviting overseas guest speakers to explore the basic understanding of gastric cancer, focusing on next generation pathology diagnosis, robotic surgery, and functional endoscopy which will prevalently continue to be introduced in the coming years. We also wish to discuss the medical challenges such as scirrhous gastric cancer that we must overcome, and to share the latest information with a view beyond the realms of the next generation in the symposiums, special lectures, presidential lecture, and educational lectures, probing into new treatments based on the experiences in battling gastric cancer, and to take the first step to paving the way toward building alternative systems.

Atsushi Ochiai, M.D., Ph.D.
Congress President
The 92nd Annual Meeting of the Japanese Gastric Cancer Association
(Director of Exploratory Oncology Research & Clinical Trial Center, National Cancer Center)

※につきましては、身分を証明できる証明書などをご提示ください。

• 事前登録はありません。
• つり銭のいらないように現金をご用意ください。クレジットカードは使えません。